Skip to main content
SpringerLink
Log in

Gender and Age in the Biochemical Assessment of Cure of Acromegaly

  • Published:
Pituitary Aims and scope Submit manuscript

Abstract

The principal biochemical criteria for cure in acromegaly are normalization of both glucose-suppressed GH levels and IGF-I levels. As we have reported previously, measurement of GH by highly sensitive assay in conjunction with IGF-I levels has led to are-appraisal of “normal” GH suppression criteria during an OGTT in subjects with acromegaly. In some patients with active acromegaly, glucose-suppressed GH levels as measured by highly sensitive assay are much lower than could previously be appreciated with less sensitive GH assays and some other patients in apparent remission have subtle abnormalities of GH suppression. A question to arise is whether gender differences in glucose-suppressed GH levels as found by others in young healthy subjects should be considered in our interpretation of OGTT criteria for cure in acromegaly. Therefore, we have evaluated parameters of GH secretion in a larger number of subjects from our cohort of postoperative patients with acromegaly and in healthy subjects in order to determine if gender or age associated differences in these parameters exist.

Ninety-two subjects with acromegaly (49 men, 43 women) and 46 age-matched healthy subjects (26 men, 20 women) were evaluated with baseline GH and IGF-I levels and nadir GH levels after a 100 g. OGTT. GH was assayed by highly sensitive IRMA (DSL). Basal GH levels were higher in female than in male healthy subjects, but the fall in GH from baseline (%suppression) was also greater in females resulting in no significant difference in mean nadir GH levels in female vs. male healthy subjects (0.09 vs. 0.08 μg/L). In the subjects with acromegaly, there were no significant gender differences in basal, %GH suppression or nadir GH levels.

Basal and nadir GH levels correlated significantly only in subjects with active disease (r = 0.84, p < .0001). Similarly, IGF-I levels correlated significantly with basal (r = 0.573, p = .0012), and nadir (r = .702, p < .0001) GH levels only in subjects with active disease. Gender differences in IGF-I levels were not apparent in any group of subjects. As expected, IGF-I levels declined with age in those groups of subjects with normal IGF-I levels. Nadir GH levels did not vary with age. In conclusion, we have not found significant gender or age-related differences in nadir GH levels and thus our data does not support separate OGTT criteria for cure in men and women with acromegaly.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Daughaday WH. New criteria for evaluation of acromegaly [editorial]. N Engl J Med 1979;301(21):1175–1176.

    Google Scholar 

  2. Lamberts SW. Acromegaly and its treatment. J Endocrinol 1997;155(Suppl 1): S49–S51; discussion S67-S71.

    Google Scholar 

  3. Jaffe CA, Barkan AL. Acromegaly. Recognition and treatment. Drugs 1994;47(3):425–445.

    Google Scholar 

  4. Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, VonWerder K, Melmed S. Criteria forcure of acromegaly:Aconsensus statement. J Clin Endocrinol Metab 2000;85(2):526–529.

    Google Scholar 

  5. Barkan AL, Beitins IZ, Kelch RP. Plasma insulin-like growth factor-I/somatomedin-C in acromegaly: Correlation with the degree of growth hormone hypersecretion. J Clin Endocrinol Metab 1988;67(1):69–73.

    Google Scholar 

  6. Schatz H, Stracke H, Zapf J. [Diagnosis in acromegaly. Insulinlike growth factor as a parameter of activity]. Dtsch Med Wochenschr 1983;108(37):1391–1395.

    Google Scholar 

  7. Clemmons DR, Van Wyk JJ, Ridgway EC, Kliman B, Kjellberg RN, Underwood LE. Evaluation of acromegaly by radioimmunoassay of somatomedin-C. N Engl J Med 1979;301(21):1138–1142.

    Google Scholar 

  8. Oppizzi G, Petroncini MM, Dallabonzana D, Cozzi R, Verde G, Chiodini PG, Liuzzi A. Relationship between somatomedin-C and growth hormone levels in acromegaly: Basal and dynamic evaluation. J Clin Endocrinol Metab 1986;63(6):1348–1353.

    Google Scholar 

  9. Freda PU, Post KD, Powell JS, Wardlaw SL. Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly. J Clin Endocrinol Metab 1998;83(11):3808–3816.

    Google Scholar 

  10. Bates AS, Evans AJ, Jones P, Clayton RN. Assessment of GH status in acromegaly using serum growth hormone, serum insulin-like growth factor-1 and urinary growth hormone excretion. Clin Endocrinol (Oxf) 1995;42(4):417–423.

    Google Scholar 

  11. Wass JA. Growth hormone, insulin-like growth factor-I and its binding proteins in the followup of acromegaly. J Endocrinol 1997;155(Suppl 1):S17–S19; discussion S21.

    Google Scholar 

  12. Clemmons DR, Van Wyk JJ. Factors controlling blood concentration of somatomedin C. Clin Endocrinol Metab 1984;13(1):113–143.

    Google Scholar 

  13. Le Roith D. Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors. N Engl J Med 1997;336(9):633–640.

    Google Scholar 

  14. Hartman ML, Veldhuis JD, Thorner MO. Normal control of growth hormone secretion. Horm Res 1993;40(1-3):37–47.

    Google Scholar 

  15. Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E, Furlanetto R, Rogol AD, Kaiser DL, Thorner MO. Effects of sex and age on the 24-hour profile of growth hormone secretion in man: Importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 1987;64(1):51–58.

    Google Scholar 

  16. Weltman A, Weltman JY, Hartman ML, Abbott RD, Rogol AD, Evans WS, Veldhuis JD. Relationship between age, percentage body fat, fitness, and 24-hour growth hormone release in healthy young adults: Effects of gender. J Clin Endocrinol Metab 1994;78(3):543–548.

    Google Scholar 

  17. Pincus SM, Gevers EF, Robinson IC, van den Berg G, Roelfsema F, Hartman ML, Veldhuis JD. Females secrete growth hormone with more process irregularity than males in both humans and rats. Am J Physiol 1996;270(1 Pt 1):E107–E115.

    Google Scholar 

  18. Winer LM, Shaw MA, Baumann G. Basal plasma growth hormone levels in man: New evidence for rhythmicity of growth hormone secretion. J Clin Endocrinol Metab 1990;70(6):1678–1686.

    Google Scholar 

  19. Weissberger AJ, Ho KK, Lazarus L. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab 1991;72(2):374–381.

    Google Scholar 

  20. Jaffe CA, Ocampo-Lim B, Guo W, Krueger K, Sugahara I, Demott-Friberg R, Barkan AL. Growth hormone secretory dynamics over the menstrual cycle. Endocr J 2000;47(5):549–556.

    Google Scholar 

  21. Chapman IM, Hartman ML, Straume M, Johnson ML, Veldhuis JD, Thorner MO. Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women. J Clin Endocrinol Metab 1994;78(6):1312–1319.

    Google Scholar 

  22. Breier BH, Gallaher BW, Gluckman PD. Radioimmunoassay for insulin-like growth factor-I: Solutions to some potential problems and pitfalls. J Endocrinol 1991;128(3):347–357.

    Google Scholar 

  23. Frantz AG, Rabkin MT. Effects of estrogen and sex difference on secretion of human growth hormone. J Clin Endocrinol Metab 1965;25(11):1470–1480.

    Google Scholar 

  24. Engstrom BE, Karlsson FA, Wide L. Gender differences in diurnal growth hormone and epinephrine values in young adults during ambulation. Clin Chem 1999;45(8 Pt 1):1235–1239.

    Google Scholar 

  25. van den Berg G, Veldhuis JD, Frolich M, Roelfsema F. An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender difference in mean GH concentrations in men and premenopausal women. J Clin Endocrinol Metab 1996;81(7): 2460–2467.

    Google Scholar 

  26. Hilding A, Hall K, Wivall-Helleryd IL, Saaf M, Melin AL, Thoren M. Serum levels of insulin-like growth factor I in 152 patients with growth hormone deficiency, aged 19-82 years, in relation to those in healthy subjects. J Clin Endocrinol Metab 1999;84(6):2013–2019.

    Google Scholar 

  27. Dall R, Longobardi S, Ehrnborg C, Keay N, Rosen T, Jorgensen JO, Cuneo RC, Boroujerdi MA, Cittadini A, Napoli R, et al. The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men. GH-2000 Study Group. J Clin Endocrinol Metab 2000;85(11):4193–4200.

    Google Scholar 

  28. Burman P, Johansson AG, Siegbahn A, Vessby B, Karlsson FA. Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women. J Clin Endocrinol Metab 1997;82(2):550–555.

    Google Scholar 

  29. Johannsson G, Bjarnason R, Bramnert M, Carlsson LM, Degerblad M, Manhem P, Rosen T, Thoren M, Bengtsson BA. The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GHbinding protein, body mass index, age, and gender. J Clin Endocrinol Metab 1996;81(4):1575–1581.

    Google Scholar 

  30. Johannsson G, Rosen T, Bengtsson BA. Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults. Clin Endocrinol (Oxf) 1997;47(5):571–581.

    Google Scholar 

  31. Jaffe CA, Ocampo-Lim B, Guo W, Krueger K, Sugahara I, DeMott-Friberg R, Bermann M, Barkan AL. Regulatory mechanisms of growth hormone secretion are sexually dimorphic. J Clin Invest 1998;102(1):153–164. Gender and Biochemical Cure of Acromegaly 171

    Google Scholar 

  32. Faria AC, Bekenstein LW, Booth RA Jr, Vaccaro VA, Asplin CM, Veldhuis JD, Thorner MO, Evans WS. Pulsatile growth hormone release in normal women during the menstrual cycle. Clin Endocrinol (Oxf) 1992;36(6):591–596.

    Google Scholar 

  33. Ovesen P, Vahl N, Fisker S, Veldhuis JD, Christiansen JS, Jorgensen JO. Increased pulsatile, but not basal, growth hormone secretion rates and plasma insulin-like growth factor I levels during the periovulatory interval in normal women. J Clin Endocrinol Metab 1998;83(5):1662–1667.

    Google Scholar 

  34. Span JP, Pieters GF, Sweep CG, Hermus AR, Smals AG. Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: Role of sex hormone replacement. J Clin Endocrinol Metab 2000;85(3):1121–1125.

    Google Scholar 

  35. Cook DM, Ludlam WH, Cook MB. Route of estrogen administration helps to determine growth hormone (GH) replacement dose in GH-deficient adults. J Clin Endocrinol Metab 1999;84(11):3956–3960.

    Google Scholar 

  36. Bellantoni MF, Vittone J, Campfield AT, Bass KM, Harman SM, Blackman MR. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women:Aclinical research center study. J Clin Endocrinol Metab 1996;81(8):2848–2853.

    Google Scholar 

  37. Lieman HJ, Adel TE, Forst C, von Hagen S, Santoro N. Effects of aging and estradiol supplementation on GH axis dynamics in women. J Clin Endocrinol Metab 2001;86(8): 3918–3923.

    Google Scholar 

  38. Friend KE, Hartman ML, Pezzoli SS, Clasey JL, Thorner MO. Both oral and transdermal estrogen increase growth hormone release in postmenopausal women–a clinical research center study. J Clin Endocrinol Metab 1996;81(6): 2250–2256.

    Google Scholar 

  39. Engstrom BE, Karlsson FA, Wide L. Marked gender differences in ambulatory morning growth hormone values in young adults. Clin Chem 1998;44(6 Pt 1):1289–1295.

    Google Scholar 

  40. Jadresic A, Banks LM, Child DF, Diamant L, Doyle FH, Fraser TR, Joplin GF. The acromegaly syndrome. Relation between clinical features, growth hormone values and radiological characteristics of the pituitary tumours.Q J Med 1982;51(202):189–204.

    Google Scholar 

  41. Smals AE, Pieters GF, Smals AG, Kloppenborg PW. Sex difference in the relation between sellar volume and basal and GH-releasing hormone stimulated GH in acromegaly. Acta Endocrinol (Copenh) 1988;117(3):387–391.

    Google Scholar 

  42. van der Lely AJ, Harris AG, Lamberts SW. The sensitivity of growth hormone secretion to medical treatment in acromegalic patients: Influence of age and sex. Clin Endocrinol (Oxf) 1992;37(2):181–185.

    Google Scholar 

  43. Clemmons DR, Underwood LE. Nutritional regulation of IGFI and IGF binding proteins. Annu Rev Nutr 1991;11: 393–412.

    Google Scholar 

  44. Ho KY, Weissberger AJ. Characterization of 24-hour growth hormone secretion in acromegaly: Implications for diagnosis and therapy. Clin Endocrinol (Oxf) 1994;41(1): 75–83.

    Google Scholar 

  45. Holly JM, Cotterill AM, Jemmott RC, Shears D, al-Othman S, Chard T, Wass JA. Inter-relations between growth hormone, insulin, insulin-like growth factor-I (IGF-I), IGF-binding protein-I (IGFBP-I) and sex hormone-binding globulin in acromegaly. Clin Endocrinol (Oxf) 1991;34(4): 275–280.

    Google Scholar 

  46. Dobrashian RD, O'Halloran DJ, Hunt A, Beardwell CG, Shalet SM. Relationships between insulin-like growth factor-1 levels and growth hormone concentrations during diurnal profiles and following oral glucose in acromegaly. Clin Endocrinol (Oxf) 1993;38(6):589–593.

    Google Scholar 

  47. Parkinson C, Ryder WD, Trainer PJ. The relationship between Serum GH and Serum IGF-I in acromegaly is gender-specific. J Clin Endocrinol Metab 2001;86(11): 5240–5244.

    Google Scholar 

  48. Duncan E, Wass JA. Investigation protocol: Acromegaly and its investigation. Clin Endocrinol (Oxf) 1999;50(3): 285–293.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Columbia College of Physicians and Surgeons, New York, NY

    Pamela U. Freda, Rita E. Landman, Robert E. Sundeen & Kalmon D. Post

Authors
  1. Pamela U. Freda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rita E. Landman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert E. Sundeen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kalmon D. Post
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Freda, P.U., Landman, R.E., Sundeen, R.E. et al. Gender and Age in the Biochemical Assessment of Cure of Acromegaly. Pituitary 4, 163–171 (2001). https://doi.org/10.1023/A:1015314906972

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015314906972

Search

Navigation